ClinicalTrials.gg
RecruitingNCT06384079Updated Nov 26, 2024

Duration of Ureteral Rest Prior to Ureteral Reconstruction Surgery

An observational study in Ureteral Stricture, sponsored by Northwestern University. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-11-26.

Sponsored by Northwestern University · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Nov 2025, 1 year ago, but the record still lists the study as recruiting.
  • Started Sep 2024; still recruiting 2 years 1 month later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
25
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 116 studies in Constriction, Pathologic with a site in United States — 14 open to participants now, 18 under way, 2 of them phase 3. Constriction, Pathologic · United States.

Planned enrollment
23rd of 32
25 · median 62
Started
2024
with 6 others
Observational
33 of 116
4 open now
Primary completion
2025-11
later than 2 of 17 live
Registered
106th of 116
by date
Lead sponsor
3 of 116
Northwestern University

Among the 116 studies in Constriction, Pathologic with a site in United States, this one is the 23rd largest by planned enrollment of the 32 observational ones that give a count, is one of 7 that started in 2024, is one of 33 observational ones, reaches primary completion later than 2 of the 17 other live ones, and was the 106th registered.

Constriction, Pathologic

457 studies on the registry are indexed under Constriction, Pathologic; 110 are open to participants now.

Browse Constriction, Pathologic studies →

Open to participants now

14 of the 116 studies in Constriction, Pathologic with a site in United States are open now. Recruiting first, the newest first:

8 more — sign in →

All 14 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 67 Constriction, Pathologic studies recruiting now, 34 (51%) set no upper age limit and 14 (21%) stop at 75 or younger; 8 take children under 18; 1 takes healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 116 studies in Constriction, Pathologic with a site in United States, or all of them as a file.
02

Study summary

Our objective is to assess the effect of duration of ureteral rest, defined as time from conversion of ureteral stent to percutaneous nephrostomy, on stricture length prior to ureteral reconstruction surgery.

03

Conditions studied

  • Ureteral Stricture
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Subjects over 18 years of age undergoing surgery to fix the ureter.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • >18 years of age
  • Undergoing ureteral reconstruction surgery for ureteral stricture with conversion of an indwelling stent to a percutaneous nephrostomy tube for ureteral rest
  • Willing to sign form
  • Able to read and understand informed consent form

Exclusion criteria

Exclusion Criteria:

  • \<18 years of age
  • Inability to provide
  • Members of vulnerable patient populations
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
25 participants (estimated)
Patient registry
No

Groups and cohorts

  • Endoscopic Evaluation

    Antegrade and retrograde pyelogram will be completed prior to definitive ureteral repair

    Procedure: Antegrade and retrograde pyelogram

Interventions

  • ProcedureAntegrade and retrograde pyelogram

    Participation in the study will guarantee that participants will receive this procedure.

06

What researchers measure

Primary outcomes

  1. Ureteral stricture length measured by antegrade or retrograde pyelogram

    Time frame: 2 weeks and 6 weeks post procedure

Secondary outcomes

  1. Ureteral Stricture Quality will be graded as either narrowed or obliterated segment.

    Time frame: 2 weeks and 6 weeks post procedure

07

Study locations

1 of 1 sites recruiting
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2024 (actual). Primary completion is estimated for Nov 2025, 14 months after the start.

Of 52 non-industry observational studies under Constriction, Pathologic, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 62. This study's planned 14 months is below that.

Counting every sponsor, half of 64 studies reached it within 31 months; a quarter within 19 and three quarters within 62.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 19, 2024
First posted
Apr 25, 2024
StartActual
Sep 24, 2024
Primary completionEst.
Nov 2025
CompletionEst.
Nov 2030
Last update
Nov 26, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 26, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06384079
Responsible party
Ziho Lee (Principal Investigator, Northwestern University) — Principal investigator
First posted
Apr 25, 2024
Start date
Sep 24, 2024
Primary completion
Nov 2025 (estimated)
Completion
Nov 2030 (estimated)
Last update
Nov 26, 2024

Study contacts

Emily Ji
Contact
emily.ji@nm.org
312-695-8146

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion